Alterity Therapeutics (PRNAD) Short term Debt (2011 - 2015)

Alterity Therapeutics (PRNAD) has reported Short term Debt for 4 consecutive years, with $424.62 the latest figure, recorded in Q4 2015.

• In Q4 2015, Short term Debt changed N/A year-over-year to $424.62; the TTM figure through Dec 2015 stood at $424.62 (changed N/A YoY), while the FY2015 annual figure was $9.33, changed N/A from the prior year.
• Short term Debt came in at $424.62 for Q4 2015 at Alterity Therapeutics, up from $9.33 in the prior quarter.
• The five-year high for Short term Debt was $865088.8 in Q2 2013, with the low at $9.33 in Q2 2015.
• Average Short term Debt over 4 years is $386122.0, with a median of $339441.3 recorded in 2012.
• Across the five-year window, Short term Debt declined 10.14% in 2012 and soared 154.86% in 2013, its largest moves.
• Year by year, Short term Debt stood at $336559.4 in 2011, then surged by 132.82% to $783567.3 in 2012, then climbed by 10.4% to $865088.8 in 2013, then tumbled by 99.95% to $424.62 in 2015.
• According to Business Quant data, Short term Debt over the past three periods registered $424.62, $9.33, and $865088.8 for Q4 2015, Q2 2015, and Q2 2013 respectively.